ZYPREXA 10 mg, coated tablet 28 tablets, parallel import (PHARMA LAB)
Active ingredients: Olanzapine
Commercialized according to BDPMDispensing in France: Prescription only
Coated tablet28 tablets, parallel import (PHARMA LAB)orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ZYPREXA 10 mg, comprimé enrobé
- Pharmaceutical form
- comprimé enrobé
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) aluminium de 28 comprimé(s) (distributeur parallèle : PHARMA LAB)
- Marketing authorisation holder
- CHEPLAPHARM REGISTRATION (ALLEMAGNE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 2 Sept 2013
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60841335CIP74950709CIP133400949507092Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| OLANZAPINEcomprimé | 10 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.